openPR Logo
Press release

Increasing Utilization of Antiviral Drugs, During the COVID-19 Outbreak, to Promote the Development of Global Antiviral Therapies Market

03-17-2021 03:50 AM CET | Health & Medicine

Press release from: Research Dive

Research Dive

Research Dive

According to antiviral therapies market analysis by Research Dive, the global market forecast will surpass $66,016.5 million in 2027, growing at a 3.1% CAGR from $51,913.1 million in the year2019.

Antiviral Therapies Market, COVID-19 Impact:

The global antiviral therapies market has responded positively to the pandemic owing to rise in the utilization of antiviral drugs in the development of effective medicines for the COVID-19 treatment. In addition, leading players in the global marketplace are adopting strategies such as collaborations and partnerships to strengthen their place in the global marketplace. For instance, in May 2020, Merck & Co., Inc. made a collaboration with Ridgeback Biotherapeutics LP, a biotechnology company, to develop EIDD-2801, which is an oral antiviral candidate for treatment of COVID-19 patents. Through this collaboration, both companies aimed to develop innovative, safe and effective vaccines againstSARS-CoV-2 through antiviral therapies. This factor is predicted to fuel the growth of the market in the pandemic time.

For More Detail Insights, Download Sample Copy of the Report at:

Antiviral Therapies Market, Overview:

The significant factor for the antiviral therapies market growth includes increasing usage of antiviral in HIV diagnosis and hepatitis C treatment. As per Centers of Disease Control and Prevention (CDC), more than 38.0 million people were living with HIV in 2019 and about 52% of the people are were diagnosed with HIV in the U.S. Globally, around 53% of children and 68% of adults were living with HIV/AIDS requiring continuous antiretroviral therapy. Antiretroviral and antiviral therapies have been proven to be an effective way to diagnose HIV/AIDS. This aspect is predicted to fuel the market growth in the estimated time. Further, there has been adoption of new technologies such as nanotechnology in the manufacturing of antivirals to produce improved drugs that are capable of functioning against emerging viral diseases. This aspect is anticipated to create ample growth opportunities for the market in the upcoming years. However, high cost of the treatment and drug price are major limiting factors for the antiviral therapies market growth in the forecast timeframe.

Antiviral Therapies Market, Segmentation Analysis:

The herpes antiviral drug type is expected to rise at a faster rate and is predicted to reach a revenue up to $5,480.7 million by 2027. Increasing cases of herpes among population in the world is estimated to be the main boosting factor for the market growth in the prediction period. According to National Institutes of Drugs, in the U.S. about 90% of people are affected by herpes by the age of 50. This aspect is predicted to impel the demand for herpes antiviral drugs and is estimated to fuel the market growth in the forecast timeframe.

Connect with Analyst to Reveal How COVID-19 Impacting On Market:

The online pharmacy distribution channel is expected to be a lucrative sub-segment in the coming years and is estimated to rise at a healthy CAGR of 5.0% during the review period. Due to lower prices medicines online, people are interested to buy from online retailers, which is estimated to be a major driver for the sub-segment growth in the forecast time. Online pharmacies offer lower pricing than conventional stores, with lower transaction & product costs, efficient delivery and simple ordering process. This aspect is predicted to propel the growth of the market in the analysis period.

Antiviral Therapies Market, Regional Insights:

The market in Asia-Pacific will witness growth at a faster rate of 4.1% CAGR and is estimated to generate significant investment opportunities for the market players in the forecast time. According to WHO, western pacific region has a high incidence of hepatitis B & C with high prevalence rate of liver cancer in the several countries such as India, China, South Korea and Vietnam. This is majorly due to excessive alcohol consumption, mother to child transmission and other reasons. This factor is predicted to fuel the demand for antiviral drugs in the forecast region.

Download the sample report to delve into the North America, Europe and LAMEA share in the global antiviral therapies market.

Antiviral Therapies Market, Significant Market Players:

1. GlaxoSmithKline plc
2. Gilead Sciences, Inc.
3. F. Hoffmann-La Roche Ltd
4. Bristol-Myers Squibb Company
5. Abbott
6. Johnson & Johnson Services, Inc.
7. AstraZeneca
8. AbbVie Inc.
9. Aurobindo Pharma
10. Merck & Co., Inc.

Porter’s Five Forces Analysis for Antiviral Therapies Market:

• Bargaining Power of Suppliers: Antiviral therapies market contains huge concentration of dealers and selling control is predicted to be more, resulting in HIGH bargaining power of dealers.

• Bargaining Power of Consumers: This market has huge number of consumers, but cost associated with antiviral therapies is high which is delivering HIGH bargaining control of consumer.

• Threat of New Entrants: This market requires huge investments for product designing as well as manufacturing, and increasing purchaser demand is creating vast growth prospects and delivering MODERATE threat of new entrants.

• Threat of Substitutes: Customers may adopt substitute products owing to high cost of antiviral drugs and deliver MODERATE risk of alternative products.

• Rivalry Among Market Players: This market consists of prominent players. These players are focusing on collaborations and partnerships to increase their market share. These are most common strategies adopted by prominent players resulting in HIGH competition in the market.

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Follow us on:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing Utilization of Antiviral Drugs, During the COVID-19 Outbreak, to Promote the Development of Global Antiviral Therapies Market here

News-ID: 2257402 • Views: 569

More Releases from Research Dive

Digital Health Market Report 2020: Witness a Sustainable Growth over 2027
A newest report on the global digital health market has been added by Research Dive to its repository. The report presents thorough insights on the impact of COVID-19 pandemic on the present and forthcoming growth of the global industry, by scrutinizing important factors such as key drivers & limitations, newest trends & advances, regional market circumstances, and size & scope of the market in the course of the pandemic. The
North America Orthopedic Implants Market
According to a new report published by Research Dive, titled, "Orthopedic Implants Market : North America Opportunity Analysis and Industry Forecast, 2018-2025," the North America orthopedic implants market size was valued at $23,461 million in 2018, and is projected to reach $30,646 million by 2025, growing at a CAGR of 3.9% from 2019 to 2025. Orthopedic implant is a medical device surgically placed inside the body to restore bone function
North America Sports Medicine Market Revenue, Key Players, Supply-Demand, Invest …
According to a new report published by Research Dive, titled, "Sports Medicine Devices Market : North America Opportunity Analysis and Industry Forecast, 2018-2025," the North America sports medicine devices market was valued at $3,580 million in 2018, and is expected to reach $5,382 million by 2025, registering a CAGR of 6.7% from 2019 to 2025. Sports medicine deals with the physical fitness of athletes. It is used for prevention and
North America Mechanical Ventilator Market Projected to Deliver Greater Revenues
According to a new report published by Research Dive, titled, "North America Mechanical Ventilator Market : Opportunity Analysis and Industry Forecast, 2019-2025," the North America mechanical ventilator market was valued at $623.4 million in 2018 and is projected to reach $963.4 million by 2025, growing at a CAGR of 6.3% from 2019-2025. Mechanical ventilator is also known as a respirator or breathing machine. It provides oxygen to a patient who is

All 5 Releases

More Releases for Antiviral

Antiviral Drugs Market Size, Report 2022-2030
Acumen Research and Consulting has announced the addition of the "Antiviral Drugs Market" report to their offering. The Antiviral Drugs Market Report 2030 is an in depth study analyzing the current state of the Antiviral Drugs Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Antiviral Drugs Market provides analysis of global market covering the industry trends, recent
Antiviral Drugs Market
“Antiviral Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market
Antiviral therapies Market: High Cost of Antiviral therapies Is a Major Restrain …
Post COVID-19 Impact on Antiviral Therapies Market –With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive’ group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive
Coronavirus's Impact On Antiviral Packaging Market
Antiviral Packaging Market – An Overview The coronavirus pandemic keeps on revamping the idea of worldwide society in 2020, and with it changes the perspectives and practices of buyers now and for a long time to come. In any case, the prompt effect on buyers’ interests about viral introduction and questions hanging about the infection’s capacity to make due on surfaces, may fuel an any longer enduring interest for new bundling
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an
03-09-2017 | Health & Medicine
Antiviral Drugs Market: Demand for Antiviral Drugs to Remain High from HIV Infec …
With the significant increase in the incidence of viral infections, the global antiviral drugs market is witnessing a substantial rise in its size and valuation. The increasing prevalence of chronic infections, such as HIV/AIDS and hepatitis B, which require long-term treatment, is also adding considerably to the growth of this market. Going forward, the strong focus of drugmakers on research and developments, resulting in innovation and advancements in drugs and